José Manuel
Aramendía Beitia
Consultor Médico
Marta
Santisteban Eslava
Consultora Médica
Publications by the researcher in collaboration with Marta Santisteban Eslava (13)
2024
2022
-
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
Cancers, Vol. 14, Núm. 12
2020
-
Complete cytoreductive surgery, the key factor for survival in advanced ovarian cancer. Experience of an intermediate volume hospital
European Journal of Gynaecological Oncology, Vol. 41, Núm. 6, pp. 906-912
-
The impact of secondary cytoreductive surgery on survival in first recurrence of platinum sensitive epithelial ovarian cancer
European Journal of Gynaecological Oncology, Vol. 41, Núm. 4, pp. 523-530
2018
-
Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience
Breast Journal, Vol. 24, Núm. 4, pp. 473-479
-
Erratum: Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial (Brachytherapy (2018) 17(5) (734–741), (S1538472118300898) (10.1016/j.brachy.2018.04.007))
Brachytherapy
-
Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial
Brachytherapy, Vol. 17, Núm. 5, pp. 734-741
2016
-
Multicatheter breast implant during breast conservative surgery: Novel approach to deliver accelerated partial breast irradiation
Brachytherapy, Vol. 15, Núm. 4, pp. 485-494
2015
-
37th Annual San Antonio Breast Cancer Symposium. Summary of the most important translational and clinical contributions
Revista de Senologia y Patologia Mamaria
-
Safety and efficacy of temsirolimus under compassionate use in heavily pretreated patients with poor-prognosis solid tumors
Minerva Chirurgica
2013
2010
-
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer
Cancer Chemotherapy and Pharmacology, Vol. 65, Núm. 3, pp. 457-465
2006
-
Docetaxel administered during pregnancy for inflammatory breast carcinoma
Clinical Breast Cancer, Vol. 6, Núm. 6, pp. 533-534